Effects of hepatitis C virus gene NS2 on the expressions of Bcl-2 and Bax in HepG2 cells

Journal of the Pakistan Medical Association

Volumn 64, Issue 10, 2014, Pages 1127-1131

  Fan, Wanhu ^a   Du, Fenjing ^a   Liu, Xiaojing ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bax; Bcl 2; Hepatitis C virus; Liver cancer cell; NS2

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; CORE PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; BCL2 PROTEIN, HUMAN; NS2 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA SEQUENCE; EXPRESSION VECTOR; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; NONSTRUCTURAL PROTEIN 2 GENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; VIRUS GENE; WESTERN BLOTTING; CULTURE TECHNIQUE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; VIROLOGY;

BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84907464500     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Huang JF, Yu ML, Dai CY, Chuang WL. Glucose abnormalities in hepatitis C virus infection. Kaohsiung J Med Sci 2013; 29: 61-8.
2. Kallwitz ER. Recurrent hepatitis C virus after transplant and the importance of plasma cells on biopsy. World J Gastroenterol 2013, 19: 158-60.
3. Ansari IU, Striker R. Subtype specific differences in NS5A domain II reveals involvement of proline at position 310 in cyclosporine susceptibility of hepatitis C virus. Viruses 2012; 4: 3303-15.
4. Das S, Shetty RK, Kumar A, Shridharan RN, Tatineni R, Chi G, et al. Monoclonal Antibodies against Hepatitis C Genotype 3a Virus Like Particle Inhibit Virus Entry in Cell Culture System. PLoS One 2012; 8: 19-23.
5. Larrubia JR, Lokhande MU, García-Garzón S, Miquel J, González- Praetorius A, Parra-Cid T, et al. Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation. J Viral Hepat 2012; 20: 85-94.
6. Derbala M, Rizk N, Shebl F, Alkaabi S, Eldweik N, John A, et al. Interleukin-28 and hepatitis C virus genotype-4: Treatmentinduced clearance and liver fibrosis. World J Gastroenterol 2012; 18: 7003-8.
7. Li Cavoli G, Zagarrigo C, Schillaci O, Servillo F, Tralongo A, Coglitore M, et al. Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepat Res Treat 2012; 37: 518-21.
8. Jeong SW, Jang JY, Chung RT. Hepatitis C virus and hepatocarcinogenesis. Clin Mol Hepatol 2012; 18: 347-56.
9. Zekri AR, Hassan ZK, Bahnassy AA, Sherif GM, ELdahshan D, Abouelhoda M, et al. Molecular Prognostic Profile of Egyptian HCC Cases Infected with Hepatitis C Virus. Asian Pac J Cancer Prev 2012; 13: 5433-8.
10. Kaukinen P, Sillanpaa M, Nousiainen L, Melén K, Julkunen I.. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKepsilon and TBK1 functions. J Med Virol 2013; 85: 71-82.
11. Costantini S, Di Bernardo G, Cammarota M, Castello G, Colonna G. Gene expression signature of human HepG2 cell line. Gene 2013; 518: 335-45.
12. Sun HY, Ou NY, Wang SW, Liu WC, Cheng TF, Shr SJ, et al. Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses. PLoS One 2012; 6: 530-4.
13. Lorenz IC. The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses 2010; 2:1635-46.
14. Foster TL, Tedbury PR, Pearson AR, Harris M. A comparative analysis of the fluorescence properties of the wild-type and active site mutants of the hepatitis C virus autoprotease NS2-3. Biochim Biophys Acta 2010; 1804: 212-22.
15. Stapleford KA, Lindenbach BD. Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1- E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol 2011; 85: 1706-17.
16. Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog 2011; 7: 278-80.
17. Tedbury P, Welbourn S, Pause A, King B, Griffin S, Harris M. The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein. J Gen Virol 2011; 92: 819-30.
18. Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, Spengler U, et al. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 2011; 85: 2891-906.
19. Ma Y, Anantpadma M, Timpe JM, Shanmugam S, Singh SM, Lemon SM, et al. Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol 2011; 85: 86-97.
20. Bussche A, Machida R, Li K, Loevinsohn G, Khander A, Wang J, et al. Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. J Hepatol 2010; 53: 797-804.